What question did this study set out to answer?

To review the core mechanisms, clinical developments, and emerging engineering strategies designed to overcome the pharmacological and immunological limitations of bispecific antibodies.

August 20, 2026International ImmunologyOpen Access

Bispecific antibodies: current advances and future perspectives

View Full Paper

Ask AI

Bookmark

Authors

THToshiya HinoKeio University YIYusuke ItoKeio University YKYuki KagoyaKeio University

Discussion

Member takes

Implication

Narrative review highlights advances in bispecific antibodies across malignancies, suggesting engineered formats and delivery platforms overcome therapeutic barriers.

Key Points

To review the core mechanisms, clinical developments, and emerging engineering strategies designed to overcome the pharmacological and immunological limitations of bispecific antibodies.
Synthesized preclinical and clinical literature evaluating bispecific antibodies across hematologic malignancies and solid tumors.
Evaluated structural engineering approaches, including Fc fusion, multispecific designs, and advanced vehicle-based delivery platforms.
T cell-engaging bispecific antibodies directed at CD3 demonstrate substantial clinical efficacy in hematologic cancers, with ongoing trials showing promise in solid tumors.
Primary therapeutic hurdles include short circulating half-lives, tumor antigen escape, off-tumor toxicity, and inadequate costimulation for sustained T cell activation.
Novel modifications, including armored molecular frameworks, extracellular vesicles, and nanoparticle delivery systems, enhance pharmacokinetics and targeted antitumor activity.

Cite This Study

Hino et al. (2026) studied this question.

synapsesocial.com/papers/6a86b5eb8a91293e6a1cd854 https://doi.org/10.1093/intimm/dxag044

View Full Paper

Ask AI

Bookmark

Implication

Narrative review highlights advances in bispecific antibodies across malignancies, suggesting engineered formats and delivery platforms overcome therapeutic barriers.

Bispecific antibodies: current advances and future perspectives

Discussion

Member takes

Implication

Key Points

Cite This Study

Bispecific antibodies: current advances and future perspectives

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider